Mariner
KRON

Mariner’s Kronos Bio KRON Stock Holding History

Mariner’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,041,031
Closed -$1.29M – 3354
2024
Q2 		$1.29M Buy
1,041,031
+962,231
+1,221% +$980K ﹤0.01% 1346
2024
Q1 		$102K Buy
+78,800
New +$89.8K ﹤0.01% 2926
2023
Q4 		– Sell
-917,436
Closed -$1.19M – 3118
2023
Q3 		$1.19M Buy
917,436
+2,105
+0.2% +$3.4K ﹤0.01% 1226
2023
Q2 		$1.57M Buy
+915,331
New +$1.45M ﹤0.01% 1070
2023
Q1 		– Sell
-10,487
Closed -$17K – 2836
2022
Q4 		$17K Buy
+10,487
New +$24.1K ﹤0.01% 2693

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mariner's KRON Position: Q3 2024 in Review

Mariner sold out of Kronos Bio (KRON) in Q3 2024, closing a stake of 1,041,031 shares — an estimated $1.29M sold.

Mariner first reported a position in KRON in Q4 2022 and held it in 5 quarters. The position peaked at $1.57M in Q2 2023. 53 funds tracked by Wall St. Rank hold KRON as of Q3 2024.

  • Mariner reported no remaining Kronos Bio position as of Q3 2024 after selling out during the quarter.
  • Mariner sold 1,041,031 Kronos Bio shares in Q3 2024, an estimated $1.29M.
  • Mariner first reported a position in Kronos Bio in Q4 2022 and held it in 5 quarters.
  • Mariner's Kronos Bio position peaked at $1.57M in Q2 2023.
  • 53 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2024.

Based on Mariner's 13F filing for Q3 2024, filed 13 Nov 2024.